INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 50 filers reported holding INSMED INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $9,637,000 | -63.5% | 11,525,000 | -57.5% | 0.01% | -64.3% |
Q2 2019 | $26,398,000 | +46.4% | 27,147,000 | +52.2% | 0.01% | +40.0% |
Q1 2019 | $18,026,000 | +68.8% | 17,832,000 | +19.0% | 0.01% | +42.9% |
Q4 2018 | $10,681,000 | +39.7% | 14,980,000 | +65.0% | 0.01% | +75.0% |
Q3 2018 | $7,645,000 | +1.2% | 9,080,000 | +10.3% | 0.00% | 0.0% |
Q2 2018 | $7,556,000 | +71.8% | 8,230,000 | +64.6% | 0.00% | +33.3% |
Q1 2018 | $4,397,000 | – | 5,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |